Blockade of nicotinic acetylcholine receptors suppresses hippocampal long-term potentiation in wild-type but not apoE4 targeted replacement mice

Journal of Neuroscience Research

Volumn 82, Issue 6, 2005, Pages 771-777

  Yun, Sung Hwan ^a,b,c   Park, Kyung A ^b,c   Sullivan, Patrick ^d   Pasternak, Joseph F ^a,b,c   LaDu, Mary Jo ^e   Trommer, Barbara L ^a,b,c,f  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Division of Neurology   (United States)

^c ENH Research Institute   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^f EVANSTON NORTHWESTERN HEALTHCARE   (United States)

Author keywords

Alzheimer's disease; Dentate gyrus; Hippocampal slices; Mecamylamine

Indexed keywords

APOLIPOPROTEIN E4; MECAMYLAMINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT;

ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CHOLINERGIC RECEPTOR BLOCKING; CONTROLLED STUDY; DENTATE GYRUS; EXCITATORY POSTSYNAPTIC POTENTIAL; GENE TARGETING; HIPPOCAMPUS; LONG TERM POTENTIATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYNAPTIC TRANSMISSION; THETA RHYTHM; WILD TYPE;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; DOSE-RESPONSE RELATIONSHIP, RADIATION; ELECTRIC STIMULATION; EXCITATORY POSTSYNAPTIC POTENTIALS; HIPPOCAMPUS; HUMANS; LONG-TERM POTENTIATION; MALE; MECAMYLAMINE; MICE; MICE, TRANSGENIC; NICOTINIC ANTAGONISTS; RECEPTORS, NICOTINIC; SYNAPTIC TRANSMISSION; TIME FACTORS;

EID: 28544450317     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20684     Document Type: Article

References (58)

1. Abdulla FA, Calaminici MR, Stephenson JD, Sinden JD. 1993. Chronic treatments with cholinoceptor drugs influence spatial learning in rats. Psychopharmacology 111:508-511.
2. Arendt T, Schindler C, Bruckner MK, Eschrich K, Bigl V, Zedlick D, Marcova L. 1997. Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele. J Neurosci 17:516-529.
3. Bartus RT, Dean RL, III, Beer B, Lippa AS. 1982. The cholinergic hypothesis of geriatric memory dysfunction. Science 217:408-414.
4. Bliss TV, Collingridge GL. 1993. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361:31-39.
5. Buccafusco JJ, Jackson WJ. 1991. Beneficial effects of nicotine administered prior to a delayed matching-to-sample task in young and aged monkeys. Neurobiol Aging 12:233-238.
6. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA. 1993. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261:921-923.
7. Curran BP, O'Connor JJ. 2003. The inhibition of long-term potentiation in the rat dentate gyrus by pro-inflammatory cytokines is attenuated in the presence of nicotine. Neurosci Lett 344:103-106.
8. Dajas-Bailador F, Wonnacott S. 2004. Nicotinic acetylcholine receptors and the regulation of neuronal signalling. Trends Pharmacol Sci 25: 317-324.
9. Deary IJ, Whiteman MC, Pattie A, Starr JM, Hayward C, Wright AF, Carothers A, Whalley LJ. 2002. Cognitive change and the APOE epsilon 4 allele. Nature 418:932.
10. Decker MW. 1995. Animal models of cognitive function. Crit Rev Neurobiol 9:321-343.
11. Dong LM, Weisgraber KH. 1996. Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins. J Biol Chem 271:19053-19057.
12. Frazier CJ, Strowbridge BW, Papke RL. 2003. Nicotinic receptors on local circuit neurons in dentate gyrus: a potential role in regulation of granule cell excitability. J Neurophysiol 89:3018-3028.
13. Freir DB, Herron CE. 2003. Nicotine enhances the depressive actions of A beta 1-40 on long-term potentiation in the rat hippocampal CA1 region in vivo. J Neurophysiol 89:2917-2922.
14. Fujii S, Sumikawa K. 2001. Acute and chronic nicotine exposure reverse age-related declines in the induction of long-term potentiation in the rat hippocampus. Brain Res 894:347-353.
15. Fujii S, Ji Z, Morita N, Sumikawa K. 1999. Acute and chronic nicotine exposure differentially facilitate the induction of LTP. Brain Res 846: 137-143.
16. Fujii S, Ji Z, Sumikawa K. 2000. Inactivation of α7 ACh receptors and activation of non-α7 Ach receptors both contribute to long term potentiation inducation in the hippocampal CA1 region. Neurosci Lett 286:134-138.
17. Gray R, Rajan AS, Radcliffe KA, Yakehiro M, Dani JA. 1996. Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature 383:713-716.
18. Grootendorst J, Bour A, Vogel E, Kelche C, Sullivan PM, Dodart JC, Bales K, Mathis C. 2005. Human apoE targeted replacement mouse lines: h-apoE4 and h-apoE3 mice differ on spatial memory performance and avoidance behavior. Behav Brain Res 159:1-14.
19. Herz J, Beffert U. 2000. Apolipoprotein E receptors: linking brain development and Alzheimer's disease. Nat Rev Neurosci 1:51-58.
20. Hunter BE, de Fiebre CM, Papke RL, Kern WR, Meyer EM. 1994. A novel nicotinic agonist facilitates induction of long-term potentiation in the rat hippocampus. Neurosci Lett 168:130-134.
21. Kang HJ, Schuman EM. 1995. Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus. Science 267:1658-1662.
22. Klein RC, Yakel JL. 2004. Inhibition of nicotinic acetylcholine receptors by apolipoprotein E-derived peptides in rat hippocampal slices. Neuroscience 127:563-567.
23. Kowal RC, Herz J, Weisgraber KH, Mahley RW, Brown MS, Goldstein JL. 1990. Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein. J Biol Chem 265:10771-10779.
24. Krugers HJ, Mulder M, Korf J, Havekes L, de Kloet ER, Joels M. 1997. Altered synaptic plasticity in hippocampal CA1 area of apolipoprotein E deficient mice. Neuroreport 8:2505-2510.
25. Krzywkowski P, Ghribi O, Gagne J, Chabot C, Kar S, Rochford J, Massicotte G, Poirier J. 1999. Cholinergic systems and long-term potentiation in memory-impaired apolipoprotein E-deficient mice. Neuroscience 92:1273-1286.
26. Levi O, Jongen-Relo AL, Feidon J, Roses AD, Michaelson DM. 2003. ApoE4 impairs hippocampal plasticity isoform-specifically and blocks the environmental stimulation of synaptogenesis and memory. Neurobiol Dis 13:273-282.
27. Levin ED, Simon BB. 1998. Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology 138:217-230.
28. Levin ED, Christopher NC, Briggs SJ, Rose JE. 1993. Chronic nicotine reverses working memory deficits caused by lesions of the fimbria or medial basalocortical projection. Brain Res Cogn Brain Res 1: 137-143.
29. Mann EO, Greenfield SA. 2003. Novel modulatory mechanisms revealed by the sustained application of nicotine in the guinea-pig hippocampus in vitro. J Physiol 551:539-550.
30. Matsuyama S, Matsumoto A, Enomoto T, Nishizaki T. 2000. Activation of nicotinic acetylcholine receptors induces long-term potentiation in vivo in the intact mouse dentate gyrus. Eur J Neurosci 12:3741-3747.
31. Naie K, Manahan-Vaughan D. 2004. Regulation by metabotropic glutamate receptor 5 of LTP in the dentate gyrus of freely moving rats: relevance for learning and memory formation. Cereb Cortex 14:189-198.
32. Nomura T, Nishizaki T. 2000. Nefiracetam hippocampal neurotransmission by a mechanism independent of the piracetam and aniracetam action. Brain Res 870:157-162.
33. Palop JJ, Jones B, Kekonius L, Chin J, Yu GQ, Raber J, Masliah E, Mucke L. 2003. Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits. Proc Natl Acad Sci U S A 100:9572-9577.
34. Perry EK, Gibson PH, Blessed G, Perry RH, Tomlinson BE. 1977. Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue. J Neurol Sci 34:247-265.
35. Pidoplichko VI, DeBiasi M, Williams JT, Dani JA. 1997. Nicotine activates and desensitizes midbrain dopamine neurons. Nature 390:401-404.
36. Poirier J. 1994. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci 17:525-530.
37. Poirier J, Delisle MC, Quirion R, Aubert I, Farlow M, Lahiri D, Hui S, Bertrand P, Nalbantoglu J, Gilfix BM. 1995. Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. Proc Natl Acad Sci U S A 92:12260-12264.
38. Raber J, Wong D, Yu GQ, Buttini M, Mahley RW, Pitas RE, Mucke L. 2000. Apolipoprotein E and cognitive performance. Nature 404:352-354.
39. Radcliffe KA, Dani JA. 1998. Nicotinic stimulation produces multiple forms of increased glutamatergic synaptic transmission. J Neurosci 18: 7075-7083.
40. Roberta M, Scuri R, Brunelli M. 2001. Differectial effects of PACAP-38 on synaptic responses in rat hippocampal CA1 region. Learn Mem 8:265-271.
41. Sawada S, Yamamoto C, Ohnoshosaku T. 1994. Long-term potentiation and depression in the dentate gyrus, and effects of nicotine. Neurosci Res 20:323-329.
42. Sher E, Chen Y, Sharples TJ, Broad LM, Benedetti G, Zwart R, McPhie GI, Pearson KH, Baldwinson T, De Filippi G. 2004. Physiological roles of neuronal nicotinic receptor subtypes: new insights on the nicotinic modulation of neurotransmitter release, synaptic transmission and plasticity. Curr Top Med Chem 4:283-297.
43. Slooter AJ, Tang MX, van Duijn CM, Stern Y, Ott A, Bell K, Breteler MM, Van Broeckhoven C, Tatemichi TK, Tycko B, Hofman A, Mayeux R. 1997. Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation. JAMA 277:818-821.
44. Soininen H, Kosunen O, Helisalmi S, Mannermaa A, Paljarvi L, Talasniemi S, Ryynanen M, Riekkinen P Sr. 1995. A severe loss of choline acetyltransferase in the frontal cortex of Alzheimer patients carrying apolipoprotein epsilon 4 allele. Neurosci Lett 187:79-82.
45. Strittmatter WJ. 2001. Apolipoprotein E and Alzheimer's disease: signal transduction mechanisms. Biochem Soc Symp 67:101-109.
46. Sullivan PM, Mezdour H, Aratani Y, Knouff C, Najib J, Reddick RL, Quarfordt SH, Maeda N. 1997. Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis. J Biol Chem 272:17972-17980.
47. Teasdale GM, Nicoll JA, Fiddes M. 1997. Association of apolipoprotein E polymorphism with outcome after head injury. Lancet 2:1069-1071.
48. Trommer BL, Shah C, Yun SH, Gamkrelidze G, Pasternak ES, Ye GL, Sotak M, Sullivan PM, Pasternak JF, LaDu MJ. 2004. ApoE isoform affects LTP in human targeted replacement mice. Neuroreport 15:2655-2658.
49. Trommer BL, Shah C, Yun SH, Gamkrelidze G, Pasternak ES, Blaine SW, Manelli A, Sullivan P, Pasternak JF, LaDu MJ. 2005. ApoE isoform-specific effects on LTP: blockade by oligomeric amyloid-beta1-42. Neurobiol Dis 18:75-82.
50. Valastro B, Ghribi O, Poirier J, Krzywkowski P, Massicotte G. 2001. AMPA receptor regulation and LTP in the hippocampus of young and aged apolipoprotein E-deficient mice. Neurobiol Aging 22:9-15.
51. Veinbergs I, Jung MW, Young SJ, Van Uden E, Groves PM, Masliah E. 1998. Altered long-term potentiation in the hippocampus of apolipoprotein E-deficient mice. Neurosci Lett 249:71-74.
52. Warburton DM, Rusted JM, Fowler J. 1992. A comparison of the attentional and consolidation hypotheses for the facilitation of memory by nicotine. Psychopharmacology 108:443-447.
53. Weeber EJ, Beffert U, Jones C, Christian JM, Forster E, Sweatt JD, Herz J. 2002. Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning. J Biol Chem 277:39944-39952.
54. Weisgraber KH. 1994. Apolipoprotein E: structure-function relationships. Adv Protein Chem 45:249-302.
55. Wevers A, Burghaus L, Moser N, Witter B, Steinlein OK, Schutz U, Achnitz B, Krempel U, Nowacki S, Pilz K, Stoodt J, Lindstrom J, de Vos RA, Jansen Steur EN, Schroder H. 2000. Expression of nicotinic acetylcholine receptors in Alzheimer's disease: postmortem investigations and experimental approaches. Behav Brain Res 113:207-215.
56. Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, Delon MR. 1982. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 215:1237-1239.
57. Yun SH, Cheong MY, Mook-Jung I, Huh K, Lee C, Jung MW. 2000. Cholinergic modulation of synaptic transmission and plasticity in entorhinal cortex and hippocampus of the rat. Neuroscience 97:671-676.
58. Zhuo M, Holtzman DM, Li Y, Osaka H, DeMaro J, Jacquin M, Bu G. 2000. Role of tissue plasminogen activator receptor LRP in hippocampal long-term potentiation. J Neurosci 20:542-549.